ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Auto-Immune Disease Diagnostics for Animal Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-12N17480
Home | Market Reports | Health| Health Conditions
Global Auto Immune Disease Diagnostics for Animal Market Research Report 2024
BUY CHAPTERS

Global Auto-Immune Disease Diagnostics for Animal Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-12N17480
Report
October 2025
Pages:131
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
IDEXX Laboratories
Abaxis
Heska Corporation
Accuplex Diagnostics
Neogen Corporation
Mindray Medical International Ltd
Agfa Healthcare
Elabscience Biotechnology Co Ltd
VCA
Zoetis Inc
ID Vet
Thermo Fisher Scientific
GE Healthcare

Auto-Immune Disease Diagnostics for Animal Market

The global Auto-Immune Disease Diagnostics for Animal market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Auto-Immune Disease Diagnostics for Animal refers to the process of diagnosing autoimmune diseases in animals. Autoimmune diseases occur when the immune system mistakenly attacks and damages the body's own tissues and organs.
From a downstream perspective, Hospitals accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Auto-Immune Disease Diagnostics for Animal leading manufacturers including IDEXX Laboratories, ABAXIS, Heska Corporation, Accuplex Diagnostics, Neogen Corporation, Mindray Medical International Ltd, Agfa Healthcare, Elabscience Biotechnology Co. Ltd., VCA, Inc., Zoetis, Inc., etc., dominate supply; the top five capture approximately % of global revenue, with IDEXX Laboratories leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Auto-Immune Disease Diagnostics for Animal market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Auto-Immune Disease Diagnostics for Animal Market Report

Report Metric Details
Report Name Auto-Immune Disease Diagnostics for Animal Market
Segment by Type
Segment by Application
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company IDEXX Laboratories, ABAXIS, Heska Corporation, Accuplex Diagnostics, Neogen Corporation, Mindray Medical International Ltd, Agfa Healthcare, Elabscience Biotechnology Co. Ltd., VCA, Inc., Zoetis, Inc., ID Vet, Thermo Fisher Scientific, GE Healthcare
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Auto-Immune Disease Diagnostics for Animal study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Auto-Immune Disease Diagnostics for Animal Market report?

Ans: The main players in the Auto-Immune Disease Diagnostics for Animal Market are IDEXX Laboratories, ABAXIS, Heska Corporation, Accuplex Diagnostics, Neogen Corporation, Mindray Medical International Ltd, Agfa Healthcare, Elabscience Biotechnology Co. Ltd., VCA, Inc., Zoetis, Inc., ID Vet, Thermo Fisher Scientific, GE Healthcare

What are the Application segmentation covered in the Auto-Immune Disease Diagnostics for Animal Market report?

Ans: The Applications covered in the Auto-Immune Disease Diagnostics for Animal Market report are Hospitals, Clinic

What are the Type segmentation covered in the Auto-Immune Disease Diagnostics for Animal Market report?

Ans: The Types covered in the Auto-Immune Disease Diagnostics for Animal Market report are Test, Indication

Recommended Reports

Animal Diagnostics

Veterinary Immunology

Animal Disease Testing

1 Study Coverage
1.1 Introduction to Auto-Immune Disease Diagnostics for Animal: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Auto-Immune Disease Diagnostics for Animal Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Test
1.2.3 Indication
1.3 Market Segmentation by Application
1.3.1 Global Auto-Immune Disease Diagnostics for Animal Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Auto-Immune Disease Diagnostics for Animal Revenue Estimates and Forecasts 2020-2031
2.2 Global Auto-Immune Disease Diagnostics for Animal Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Auto-Immune Disease Diagnostics for Animal Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Auto-Immune Disease Diagnostics for Animal Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Test Market Size by Players
3.3.2 Indication Market Size by Players
3.4 Global Auto-Immune Disease Diagnostics for Animal Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Auto-Immune Disease Diagnostics for Animal Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Auto-Immune Disease Diagnostics for Animal Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Auto-Immune Disease Diagnostics for Animal Market Size by Type (2020-2031)
6.4 North America Auto-Immune Disease Diagnostics for Animal Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Auto-Immune Disease Diagnostics for Animal Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Auto-Immune Disease Diagnostics for Animal Market Size by Type (2020-2031)
7.4 Europe Auto-Immune Disease Diagnostics for Animal Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Auto-Immune Disease Diagnostics for Animal Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Auto-Immune Disease Diagnostics for Animal Market Size by Type (2020-2031)
8.4 Asia-Pacific Auto-Immune Disease Diagnostics for Animal Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Auto-Immune Disease Diagnostics for Animal Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Auto-Immune Disease Diagnostics for Animal Market Size by Type (2020-2031)
9.4 Central and South America Auto-Immune Disease Diagnostics for Animal Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Auto-Immune Disease Diagnostics for Animal Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Auto-Immune Disease Diagnostics for Animal Market Size by Type (2020-2031)
10.4 Middle East and Africa Auto-Immune Disease Diagnostics for Animal Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Auto-Immune Disease Diagnostics for Animal Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 IDEXX Laboratories
11.1.1 IDEXX Laboratories Corporation Information
11.1.2 IDEXX Laboratories Business Overview
11.1.3 IDEXX Laboratories Auto-Immune Disease Diagnostics for Animal Product Features and Attributes
11.1.4 IDEXX Laboratories Auto-Immune Disease Diagnostics for Animal Revenue and Gross Margin (2020-2025)
11.1.5 IDEXX Laboratories Auto-Immune Disease Diagnostics for Animal Revenue by Product in 2024
11.1.6 IDEXX Laboratories Auto-Immune Disease Diagnostics for Animal Revenue by Application in 2024
11.1.7 IDEXX Laboratories Auto-Immune Disease Diagnostics for Animal Revenue by Geographic Area in 2024
11.1.8 IDEXX Laboratories Auto-Immune Disease Diagnostics for Animal SWOT Analysis
11.1.9 IDEXX Laboratories Recent Developments
11.2 ABAXIS
11.2.1 ABAXIS Corporation Information
11.2.2 ABAXIS Business Overview
11.2.3 ABAXIS Auto-Immune Disease Diagnostics for Animal Product Features and Attributes
11.2.4 ABAXIS Auto-Immune Disease Diagnostics for Animal Revenue and Gross Margin (2020-2025)
11.2.5 ABAXIS Auto-Immune Disease Diagnostics for Animal Revenue by Product in 2024
11.2.6 ABAXIS Auto-Immune Disease Diagnostics for Animal Revenue by Application in 2024
11.2.7 ABAXIS Auto-Immune Disease Diagnostics for Animal Revenue by Geographic Area in 2024
11.2.8 ABAXIS Auto-Immune Disease Diagnostics for Animal SWOT Analysis
11.2.9 ABAXIS Recent Developments
11.3 Heska Corporation
11.3.1 Heska Corporation Corporation Information
11.3.2 Heska Corporation Business Overview
11.3.3 Heska Corporation Auto-Immune Disease Diagnostics for Animal Product Features and Attributes
11.3.4 Heska Corporation Auto-Immune Disease Diagnostics for Animal Revenue and Gross Margin (2020-2025)
11.3.5 Heska Corporation Auto-Immune Disease Diagnostics for Animal Revenue by Product in 2024
11.3.6 Heska Corporation Auto-Immune Disease Diagnostics for Animal Revenue by Application in 2024
11.3.7 Heska Corporation Auto-Immune Disease Diagnostics for Animal Revenue by Geographic Area in 2024
11.3.8 Heska Corporation Auto-Immune Disease Diagnostics for Animal SWOT Analysis
11.3.9 Heska Corporation Recent Developments
11.4 Accuplex Diagnostics
11.4.1 Accuplex Diagnostics Corporation Information
11.4.2 Accuplex Diagnostics Business Overview
11.4.3 Accuplex Diagnostics Auto-Immune Disease Diagnostics for Animal Product Features and Attributes
11.4.4 Accuplex Diagnostics Auto-Immune Disease Diagnostics for Animal Revenue and Gross Margin (2020-2025)
11.4.5 Accuplex Diagnostics Auto-Immune Disease Diagnostics for Animal Revenue by Product in 2024
11.4.6 Accuplex Diagnostics Auto-Immune Disease Diagnostics for Animal Revenue by Application in 2024
11.4.7 Accuplex Diagnostics Auto-Immune Disease Diagnostics for Animal Revenue by Geographic Area in 2024
11.4.8 Accuplex Diagnostics Auto-Immune Disease Diagnostics for Animal SWOT Analysis
11.4.9 Accuplex Diagnostics Recent Developments
11.5 Neogen Corporation
11.5.1 Neogen Corporation Corporation Information
11.5.2 Neogen Corporation Business Overview
11.5.3 Neogen Corporation Auto-Immune Disease Diagnostics for Animal Product Features and Attributes
11.5.4 Neogen Corporation Auto-Immune Disease Diagnostics for Animal Revenue and Gross Margin (2020-2025)
11.5.5 Neogen Corporation Auto-Immune Disease Diagnostics for Animal Revenue by Product in 2024
11.5.6 Neogen Corporation Auto-Immune Disease Diagnostics for Animal Revenue by Application in 2024
11.5.7 Neogen Corporation Auto-Immune Disease Diagnostics for Animal Revenue by Geographic Area in 2024
11.5.8 Neogen Corporation Auto-Immune Disease Diagnostics for Animal SWOT Analysis
11.5.9 Neogen Corporation Recent Developments
11.6 Mindray Medical International Ltd
11.6.1 Mindray Medical International Ltd Corporation Information
11.6.2 Mindray Medical International Ltd Business Overview
11.6.3 Mindray Medical International Ltd Auto-Immune Disease Diagnostics for Animal Product Features and Attributes
11.6.4 Mindray Medical International Ltd Auto-Immune Disease Diagnostics for Animal Revenue and Gross Margin (2020-2025)
11.6.5 Mindray Medical International Ltd Recent Developments
11.7 Agfa Healthcare
11.7.1 Agfa Healthcare Corporation Information
11.7.2 Agfa Healthcare Business Overview
11.7.3 Agfa Healthcare Auto-Immune Disease Diagnostics for Animal Product Features and Attributes
11.7.4 Agfa Healthcare Auto-Immune Disease Diagnostics for Animal Revenue and Gross Margin (2020-2025)
11.7.5 Agfa Healthcare Recent Developments
11.8 Elabscience Biotechnology Co. Ltd.
11.8.1 Elabscience Biotechnology Co. Ltd. Corporation Information
11.8.2 Elabscience Biotechnology Co. Ltd. Business Overview
11.8.3 Elabscience Biotechnology Co. Ltd. Auto-Immune Disease Diagnostics for Animal Product Features and Attributes
11.8.4 Elabscience Biotechnology Co. Ltd. Auto-Immune Disease Diagnostics for Animal Revenue and Gross Margin (2020-2025)
11.8.5 Elabscience Biotechnology Co. Ltd. Recent Developments
11.9 VCA, Inc.
11.9.1 VCA, Inc. Corporation Information
11.9.2 VCA, Inc. Business Overview
11.9.3 VCA, Inc. Auto-Immune Disease Diagnostics for Animal Product Features and Attributes
11.9.4 VCA, Inc. Auto-Immune Disease Diagnostics for Animal Revenue and Gross Margin (2020-2025)
11.9.5 VCA, Inc. Recent Developments
11.10 Zoetis, Inc.
11.10.1 Zoetis, Inc. Corporation Information
11.10.2 Zoetis, Inc. Business Overview
11.10.3 Zoetis, Inc. Auto-Immune Disease Diagnostics for Animal Product Features and Attributes
11.10.4 Zoetis, Inc. Auto-Immune Disease Diagnostics for Animal Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 ID Vet
11.11.1 ID Vet Corporation Information
11.11.2 ID Vet Business Overview
11.11.3 ID Vet Auto-Immune Disease Diagnostics for Animal Product Features and Attributes
11.11.4 ID Vet Auto-Immune Disease Diagnostics for Animal Revenue and Gross Margin (2020-2025)
11.11.5 ID Vet Recent Developments
11.12 Thermo Fisher Scientific
11.12.1 Thermo Fisher Scientific Corporation Information
11.12.2 Thermo Fisher Scientific Business Overview
11.12.3 Thermo Fisher Scientific Auto-Immune Disease Diagnostics for Animal Product Features and Attributes
11.12.4 Thermo Fisher Scientific Auto-Immune Disease Diagnostics for Animal Revenue and Gross Margin (2020-2025)
11.12.5 Thermo Fisher Scientific Recent Developments
11.13 GE Healthcare
11.13.1 GE Healthcare Corporation Information
11.13.2 GE Healthcare Business Overview
11.13.3 GE Healthcare Auto-Immune Disease Diagnostics for Animal Product Features and Attributes
11.13.4 GE Healthcare Auto-Immune Disease Diagnostics for Animal Revenue and Gross Margin (2020-2025)
11.13.5 GE Healthcare Recent Developments
12 Auto-Immune Disease Diagnostics for AnimalIndustry Chain Analysis
12.1 Auto-Immune Disease Diagnostics for Animal Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Auto-Immune Disease Diagnostics for Animal Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Auto-Immune Disease Diagnostics for Animal Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
IDEXX Laboratories
Abaxis
Heska Corporation
Accuplex Diagnostics
Neogen Corporation
Mindray Medical International Ltd
Agfa Healthcare
Elabscience Biotechnology Co Ltd
VCA
Zoetis Inc
ID Vet
Thermo Fisher Scientific
GE Healthcare
List of Tables
 Table 1. Global Auto-Immune Disease Diagnostics for Animal Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Auto-Immune Disease Diagnostics for Animal Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Auto-Immune Disease Diagnostics for Animal Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Auto-Immune Disease Diagnostics for Animal Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Auto-Immune Disease Diagnostics for Animal Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Auto-Immune Disease Diagnostics for Animal Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Auto-Immune Disease Diagnostics for Animal Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Auto-Immune Disease Diagnostics for Animal by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Auto-Immune Disease Diagnostics for Animal as of 2024)
 Table 11. Global Auto-Immune Disease Diagnostics for Animal Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Auto-Immune Disease Diagnostics for Animal Companies Headquarters
 Table 13. Global Auto-Immune Disease Diagnostics for Animal Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Auto-Immune Disease Diagnostics for Animal Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Auto-Immune Disease Diagnostics for Animal Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Auto-Immune Disease Diagnostics for Animal Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Auto-Immune Disease Diagnostics for Animal Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Auto-Immune Disease Diagnostics for Animal High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Auto-Immune Disease Diagnostics for Animal Growth Accelerators and Market Barriers
 Table 25. North America Auto-Immune Disease Diagnostics for Animal Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Auto-Immune Disease Diagnostics for Animal Growth Accelerators and Market Barriers
 Table 27. Europe Auto-Immune Disease Diagnostics for Animal Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Auto-Immune Disease Diagnostics for Animal Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Auto-Immune Disease Diagnostics for Animal Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Auto-Immune Disease Diagnostics for Animal Investment Opportunities and Key Challenges
 Table 31. Central and South America Auto-Immune Disease Diagnostics for Animal Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Auto-Immune Disease Diagnostics for Animal Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Auto-Immune Disease Diagnostics for Animal Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. IDEXX Laboratories Corporation Information
 Table 35. IDEXX Laboratories Description and Major Businesses
 Table 36. IDEXX Laboratories Product Features and Attributes
 Table 37. IDEXX Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. IDEXX Laboratories Revenue Proportion by Product in 2024
 Table 39. IDEXX Laboratories Revenue Proportion by Application in 2024
 Table 40. IDEXX Laboratories Revenue Proportion by Geographic Area in 2024
 Table 41. IDEXX Laboratories Auto-Immune Disease Diagnostics for Animal SWOT Analysis
 Table 42. IDEXX Laboratories Recent Developments
 Table 43. ABAXIS Corporation Information
 Table 44. ABAXIS Description and Major Businesses
 Table 45. ABAXIS Product Features and Attributes
 Table 46. ABAXIS Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. ABAXIS Revenue Proportion by Product in 2024
 Table 48. ABAXIS Revenue Proportion by Application in 2024
 Table 49. ABAXIS Revenue Proportion by Geographic Area in 2024
 Table 50. ABAXIS Auto-Immune Disease Diagnostics for Animal SWOT Analysis
 Table 51. ABAXIS Recent Developments
 Table 52. Heska Corporation Corporation Information
 Table 53. Heska Corporation Description and Major Businesses
 Table 54. Heska Corporation Product Features and Attributes
 Table 55. Heska Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Heska Corporation Revenue Proportion by Product in 2024
 Table 57. Heska Corporation Revenue Proportion by Application in 2024
 Table 58. Heska Corporation Revenue Proportion by Geographic Area in 2024
 Table 59. Heska Corporation Auto-Immune Disease Diagnostics for Animal SWOT Analysis
 Table 60. Heska Corporation Recent Developments
 Table 61. Accuplex Diagnostics Corporation Information
 Table 62. Accuplex Diagnostics Description and Major Businesses
 Table 63. Accuplex Diagnostics Product Features and Attributes
 Table 64. Accuplex Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Accuplex Diagnostics Revenue Proportion by Product in 2024
 Table 66. Accuplex Diagnostics Revenue Proportion by Application in 2024
 Table 67. Accuplex Diagnostics Revenue Proportion by Geographic Area in 2024
 Table 68. Accuplex Diagnostics Auto-Immune Disease Diagnostics for Animal SWOT Analysis
 Table 69. Accuplex Diagnostics Recent Developments
 Table 70. Neogen Corporation Corporation Information
 Table 71. Neogen Corporation Description and Major Businesses
 Table 72. Neogen Corporation Product Features and Attributes
 Table 73. Neogen Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Neogen Corporation Revenue Proportion by Product in 2024
 Table 75. Neogen Corporation Revenue Proportion by Application in 2024
 Table 76. Neogen Corporation Revenue Proportion by Geographic Area in 2024
 Table 77. Neogen Corporation Auto-Immune Disease Diagnostics for Animal SWOT Analysis
 Table 78. Neogen Corporation Recent Developments
 Table 79. Mindray Medical International Ltd Corporation Information
 Table 80. Mindray Medical International Ltd Description and Major Businesses
 Table 81. Mindray Medical International Ltd Product Features and Attributes
 Table 82. Mindray Medical International Ltd Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Mindray Medical International Ltd Recent Developments
 Table 84. Agfa Healthcare Corporation Information
 Table 85. Agfa Healthcare Description and Major Businesses
 Table 86. Agfa Healthcare Product Features and Attributes
 Table 87. Agfa Healthcare Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Agfa Healthcare Recent Developments
 Table 89. Elabscience Biotechnology Co. Ltd. Corporation Information
 Table 90. Elabscience Biotechnology Co. Ltd. Description and Major Businesses
 Table 91. Elabscience Biotechnology Co. Ltd. Product Features and Attributes
 Table 92. Elabscience Biotechnology Co. Ltd. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. Elabscience Biotechnology Co. Ltd. Recent Developments
 Table 94. VCA, Inc. Corporation Information
 Table 95. VCA, Inc. Description and Major Businesses
 Table 96. VCA, Inc. Product Features and Attributes
 Table 97. VCA, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. VCA, Inc. Recent Developments
 Table 99. Zoetis, Inc. Corporation Information
 Table 100. Zoetis, Inc. Description and Major Businesses
 Table 101. Zoetis, Inc. Product Features and Attributes
 Table 102. Zoetis, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Zoetis, Inc. Recent Developments
 Table 104. ID Vet Corporation Information
 Table 105. ID Vet Description and Major Businesses
 Table 106. ID Vet Product Features and Attributes
 Table 107. ID Vet Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. ID Vet Recent Developments
 Table 109. Thermo Fisher Scientific Corporation Information
 Table 110. Thermo Fisher Scientific Description and Major Businesses
 Table 111. Thermo Fisher Scientific Product Features and Attributes
 Table 112. Thermo Fisher Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Thermo Fisher Scientific Recent Developments
 Table 114. GE Healthcare Corporation Information
 Table 115. GE Healthcare Description and Major Businesses
 Table 116. GE Healthcare Product Features and Attributes
 Table 117. GE Healthcare Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. GE Healthcare Recent Developments
 Table 119. Raw Materials Key Suppliers
 Table 120. Distributors List
 Table 121. Market Trends and Market Evolution
 Table 122. Market Drivers and Opportunities
 Table 123. Market Challenges, Risks, and Restraints
 Table 124. Research Programs/Design for This Report
 Table 125. Key Data Information from Secondary Sources
 Table 126. Key Data Information from Primary Sources


List of Figures
 Figure 1. Auto-Immune Disease Diagnostics for Animal Product Picture
 Figure 2. Global Auto-Immune Disease Diagnostics for Animal Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Test Product Picture
 Figure 4. Indication Product Picture
 Figure 5. Global Auto-Immune Disease Diagnostics for Animal Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Hospitals
 Figure 7. Clinic
 Figure 8. Auto-Immune Disease Diagnostics for Animal Report Years Considered
 Figure 9. Global Auto-Immune Disease Diagnostics for Animal Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 10. Global Auto-Immune Disease Diagnostics for Animal Revenue (2020-2031) & (US$ Million)
 Figure 11. Global Auto-Immune Disease Diagnostics for Animal Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 12. Global Auto-Immune Disease Diagnostics for Animal Revenue Market Share by Region (2020-2031)
 Figure 13. Global Auto-Immune Disease Diagnostics for Animal Revenue Market Share Ranking (2024)
 Figure 14. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 15. Test Revenue Market Share by Player in 2024
 Figure 16. Indication Revenue Market Share by Player in 2024
 Figure 17. Global Auto-Immune Disease Diagnostics for Animal Revenue Market Share by Type (2020-2031)
 Figure 18. Global Auto-Immune Disease Diagnostics for Animal Revenue Market Share by Application (2020-2031)
 Figure 19. North America Auto-Immune Disease Diagnostics for Animal Revenue YoY (2020-2031) & (US$ Million)
 Figure 20. North America Top 5 Players Auto-Immune Disease Diagnostics for Animal Revenue (US$ Million) in 2024
 Figure 21. North America Auto-Immune Disease Diagnostics for Animal Revenue (US$ Million) by Type (2020 - 2031)
 Figure 22. North America Auto-Immune Disease Diagnostics for Animal Revenue (US$ Million) by Application (2020-2031)
 Figure 23. US Auto-Immune Disease Diagnostics for Animal Revenue (2020-2031) & (US$ Million)
 Figure 24. Canada Auto-Immune Disease Diagnostics for Animal Revenue (2020-2031) & (US$ Million)
 Figure 25. Mexico Auto-Immune Disease Diagnostics for Animal Revenue (2020-2031) & (US$ Million)
 Figure 26. Europe Auto-Immune Disease Diagnostics for Animal Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. Europe Top 5 Players Auto-Immune Disease Diagnostics for Animal Revenue (US$ Million) in 2024
 Figure 28. Europe Auto-Immune Disease Diagnostics for Animal Revenue (US$ Million) by Type (2020-2031)
 Figure 29. Europe Auto-Immune Disease Diagnostics for Animal Revenue (US$ Million) by Application (2020-2031)
 Figure 30. Germany Auto-Immune Disease Diagnostics for Animal Revenue (2020-2031) & (US$ Million)
 Figure 31. France Auto-Immune Disease Diagnostics for Animal Revenue (2020-2031) & (US$ Million)
 Figure 32. U.K. Auto-Immune Disease Diagnostics for Animal Revenue (2020-2031) & (US$ Million)
 Figure 33. Italy Auto-Immune Disease Diagnostics for Animal Revenue (2020-2031) & (US$ Million)
 Figure 34. Russia Auto-Immune Disease Diagnostics for Animal Revenue (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Auto-Immune Disease Diagnostics for Animal Revenue YoY (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Top 8 Players Auto-Immune Disease Diagnostics for Animal Revenue (US$ Million) in 2024
 Figure 37. Asia-Pacific Auto-Immune Disease Diagnostics for Animal Revenue (US$ Million) by Type (2020-2031)
 Figure 38. Asia-Pacific Auto-Immune Disease Diagnostics for Animal Revenue (US$ Million) by Application (2020-2031)
 Figure 39. Indonesia Auto-Immune Disease Diagnostics for Animal Revenue (2020-2031) & (US$ Million)
 Figure 40. Japan Auto-Immune Disease Diagnostics for Animal Revenue (2020-2031) & (US$ Million)
 Figure 41. South Korea Auto-Immune Disease Diagnostics for Animal Revenue (2020-2031) & (US$ Million)
 Figure 42. Australia Auto-Immune Disease Diagnostics for Animal Revenue (2020-2031) & (US$ Million)
 Figure 43. India Auto-Immune Disease Diagnostics for Animal Revenue (2020-2031) & (US$ Million)
 Figure 44. Indonesia Auto-Immune Disease Diagnostics for Animal Revenue (2020-2031) & (US$ Million)
 Figure 45. Vietnam Auto-Immune Disease Diagnostics for Animal Revenue (2020-2031) & (US$ Million)
 Figure 46. Malaysia Auto-Immune Disease Diagnostics for Animal Revenue (2020-2031) & (US$ Million)
 Figure 47. Philippines Auto-Immune Disease Diagnostics for Animal Revenue (2020-2031) & (US$ Million)
 Figure 48. Singapore Auto-Immune Disease Diagnostics for Animal Revenue (2020-2031) & (US$ Million)
 Figure 49. Central and South America Auto-Immune Disease Diagnostics for Animal Revenue YoY (2020-2031) & (US$ Million)
 Figure 50. Central and South America Top 5 Players Auto-Immune Disease Diagnostics for Animal Revenue (US$ Million) in 2024
 Figure 51. Central and South America Auto-Immune Disease Diagnostics for Animal Revenue (US$ Million) by Type (2020-2031)
 Figure 52. Central and South America Auto-Immune Disease Diagnostics for Animal Revenue (US$ Million) by Application (2020-2031)
 Figure 53. Brazil Auto-Immune Disease Diagnostics for Animal Revenue (2020-2025) & (US$ Million)
 Figure 54. Argentina Auto-Immune Disease Diagnostics for Animal Revenue (2020-2025) & (US$ Million)
 Figure 55. Middle East and Africa Auto-Immune Disease Diagnostics for Animal Revenue YoY (2020-2031) & (US$ Million)
 Figure 56. Middle East and Africa Top 5 Players Auto-Immune Disease Diagnostics for Animal Revenue (US$ Million) in 2024
 Figure 57. South America Auto-Immune Disease Diagnostics for Animal Revenue (US$ Million) by Type (2020-2031)
 Figure 58. Middle East and Africa Auto-Immune Disease Diagnostics for Animal Revenue (US$ Million) by Application (2020-2031)
 Figure 59. GCC Countries Auto-Immune Disease Diagnostics for Animal Revenue (2020-2025) & (US$ Million)
 Figure 60. Israel Auto-Immune Disease Diagnostics for Animal Revenue (2020-2025) & (US$ Million)
 Figure 61. Egypt Auto-Immune Disease Diagnostics for Animal Revenue (2020-2025) & (US$ Million)
 Figure 62. South Africa Auto-Immune Disease Diagnostics for Animal Revenue (2020-2025) & (US$ Million)
 Figure 63. Auto-Immune Disease Diagnostics for Animal Industry Chain Mapping
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Animal Auto Immune Disease Diagnostics Market Research Report 2024
Diagnosis of Autoimmune Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Autoimmune Disease Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Autoimmunity Reagents Market Research Report 2024
Global Autoimmune Diagnosis Reagents Market Research Report 2024
Autoimmune Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Animal Disease Diagnostic Market Research Report 2025
Global Animal IVD Market Research Report 2024
Global Immune in Vitro Diagnostics Market Research Report 2024
Global Animal Health Diagnosis Market Insights Forecast to 2030
Global Autoimmune Disease Drugs Market Research Report 2025
Companion Animal Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Animal Therapeutics and Diagnostics Market Insights Forecast to 2030
Global Autoimmune Thyroid Assays Market Research Report 2024
Veterinary Health Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pets Diagnostic Tests Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Autoimmune Disease Testing Market Research Report 2024
Animal Diagnostic Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Autoantibody Kit Market Insights Forecast to 2030
Veterinary Molecular Diagnostics Market

RELATED REPORTS

Global Coronary Imaging Catheter Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32P14840
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Digital Platform for Chronic Kidney Disease (CKD) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20V18395
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Continuous Glucose Monitoring Sensor Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32G20014
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Radioactive Iodine Ablation Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9U20281
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions